Bond.az White LogoBond.az Black Logo

essensys Shareholders Approve Re-Registration as Private Company

essensys shareholders approve re-registration as a private company after AIM delisting. All voting shareholders backed the resolution.

Daniel Rodriguez
ByDaniel Rodriguez- Senior Editor
|
0

LONDON - essensys plc (AIM:ESYS) shareholders voted today to approve the company's re-registration as a private company following the cancellation of its shares from trading on AIM.

The General Meeting was held at 10:00 a.m. at the company's offices at 1 Finsbury Avenue, London. Shareholders voted on a special resolution to re-register the company as a private company under the name essensys Group Limited and to adopt new articles of association.

The resolution passed with 65,253,613 votes in favor, representing 100.00% of votes cast, while 257 votes were cast against. No votes were withheld.

As of today, essensys had 66,115,842 ordinary shares in issue, with shareholders entitled to one vote per share.

The re-registration is conditional upon the cancellation of the company's admission to trading on AIM becoming effective, in accordance with Rule 41 of the AIM Rules. The resolution was referenced in a previous announcement dated May 14, 2026.

The company stated that capitalized terms used in the announcement have the same meanings as given in an offer document published by essensys Bidco Limited dated March 9, 2026.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

More News
Today / 12:34
|
401

Amber International shareholder to distribute stake pro rata

Amber International's principal shareholder distributes all Class A shares pro rata to existing shareholders; market impact and financial highlights.

0
Today / 12:33
|
213

Palladyne AI Adds Two Retired Generals to Board

Palladyne AI appoints two retired generals to its defense advisory board. Stock up 98% YTD.

0
Today / 12:32
|
381

Cellectar Plans Phase 3 Trial for WM After BTKi

Cellectar Biosciences reports promising Phase 2 results for iopofosine I 131 in Waldenström macroglobulinemia after BTKi therapy, plans Phase 3 trial.

0
Today / 08:31
|
889

Causeway Capital Boosts Melrose Stake to 5.12%

Causeway Capital increased its stake in Melrose Industries to 5.12%. The investment firm now holds over 63 million voting rights.

0
Today / 08:03
|
968

Ignitis grupė starts search for new CEO

Ignitis grupė launches CEO search in Lithuania. Learn about requirements and application deadline for the new CEO position.

0
Today / 07:33
|
417

Aquila Renewables: Adviser Withholds Fee Data

Aquila European Renewables says its investment adviser Aquila Capital has not provided complete fee information. The Board is considering legal action.

0
Today / 07:31
|
226

USA Rare Earth Plans €175M France Investment

USA Rare Earth reveals €175 million investment plan in France for metal, alloy and magnet manufacturing, aiming to create over 300 jobs by 2030.

0
Today / 07:30
|
761

Lucid Group Names Silvio Napoli CEO

Lucid Group appoints Silvio Napoli as CEO effective immediately. Stock up 12% in past week but down 38% YTD. Company faces financial challenges.

0
Today / 07:04
|
679

Mkango Reports Q1 2026 Financial Results

Mkango Resources reports Q1 2026 financial results. Details on rare earth projects, recycling operations, and SPAC merger.

0
Today / 07:02
|
274

Greatland secures $500m debt facility, OKs Havieron

Greatland Resources secures $500 million corporate debt facility and board approval for Havieron gold-copper project final investment decision.

0
Today / 07:00
|
542

Calnex director buys shares at 69.9p

Calnex Solutions non-executive director Graeme Bissett buys 28,610 shares at 69.9p each on the London Stock Exchange.

0
Today / 06:34
|
619

Redcentric Appoints Tim Sykes as CFO

Redcentric appoints Tim Sykes as CFO. With 30+ years of experience, Sykes will drive growth in the MSP business.

0
...
essensys Shareholders Approve Re-Registration as Private Company | Bond.az